Last Updated: May 23, 2024
illuminatemrd.com has 4 NS records, 8 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for illuminatemrd.com are ns-2029.awsdns-61.co.uk, ns-404.awsdns-50.com, ns-764.awsdns-31.net, ns-1414.awsdns-48.org. A records for illuminatemrd.com are 52.92.179.19, 52.92.248.83, 52.92.250.123, 52.92.138.43, 52.218.221.162, 52.92.138.83, 52.92.226.19, 52.92.180.35. We have observed illuminatemrd.com to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a AmazonS3 web server at 52.92.146.243 in United States. The website's description is: "signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it."
Search DigitalStakeout Footprint to find another asset.
52.92.179.19
52.92.248.83
52.92.250.123
52.92.138.43
52.218.221.162
52.92.138.83
52.92.226.19
52.92.180.35
No DNS AAAA records
No DNS MX records
ns-2029.awsdns-61.co.uk
ns-404.awsdns-50.com
ns-764.awsdns-31.net
ns-1414.awsdns-48.org
No DNS TXT records
illuminatemrd.com has 1 subdomains in our inventory.
AmazonS3
52.92.146.243
United States
og:locale: en_us
og:type: article
og:title: signatera overview
og:description: signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it.
og:url: https://www.natera.com/oncology/signatera-advanced-cancer-detection/
og:site_name: natera
article:publisher: https://www.facebook.com/nateragenetics
article:modified_time: 2024-04-25t23:12:21+00:00
og:image: https://www.natera.com/wp-content/uploads/2022/08/icon-medicare.png
No certificate log entry found for illuminatemrd.com. Please check back at a later time.